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The impact of impaired circadian rhythm on health has been widely studied in shift workers
and trans-meridian travelers. A part from its correlation with sleep and mood disorders, bio-
logical rhythm impairment is a recognized risk factor for cardiovascular diseases and breast
cancer. Preeclampsia is a major public health issue, associated with a significant maternal
and fetal morbidity and mortality worldwide. While the risks factors for this condition such
as obesity, diabetes, pre-existing hypertension have been identified, the underlying mecha-
nism of this multi-factorial disease is yet not fully understood.The disruption of the light/dark
cycle in pregnancy has been associated with adverse outcomes. Slightly increased risk
for “small for gestational age” babies, “low birth weight” babies, and preterm deliveries
has been reported in shift working women. Whether altered circadian cycle represents
a risk factor for preeclampsia or preeclampsia is itself linked with an abnormal circadian
cycle is less clear. There are only few reports available, showing conflicting results. In
this review, we will discuss recent observations concerning circadian pattern of blood
pressure in normotensive and hypertensive pregnancies. We explore the hypothesis that
circadian misalignments may represent a risk factor for preeclampsia. Unraveling potential
link between circadian clock gene and preeclampsia could offer a novel approach to our
understanding of this multi-system disease specific to pregnancy.
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INTRODUCTION
Preeclampsia is a pregnancy-related disease. Its physiopathology,
although not fully understood, probably involves multiple fac-
tors such as abnormal placentation, imbalance of angiogenesis
regulators, and maternal immune maladaptation. It is thought
to start early in pregnancy with a poor trophoblast invasion of
maternal spiral arteries with a subsequent placental ischemia and
insufficiency (Pennington et al., 2012). The maternal response,
which is manifest in the second half of pregnancy, is marked by an
increased systemic inflammatory response with high level of pro-
inflammatory cytokines. The widespread endothelial dysfunction
that ensues is responsible for the hypertension and proteinuria
that characterize preeclampsia (Maynard and Karumanchi, 2011).
Recently, it has been suggested that maternal hormonal distur-
bance arising from sleep deprivation or circadian rhythm dis-
ruption might impair fetal growth or lead to complications of
pregnancy (Bonzini et al., 2011).
Most physiological processes in mammals are synchronized
with the day-night cycle through an internal mechanism called the
circadian clock. This reflects the existence of underlying intrinsic
clocks with near 24 h oscillation periods. The circadian system is
organized in a hierarchic manner, with a master clock, located
in the suprachiasmatic nucleus (SCN) in the hypothalamus, syn-
chronizing billions of subsidiary oscillators located in peripheral
tissues. The term “circadian” comes from the latin “circa diem” or
“about a day,” meaning these clocks can only keep time approx-
imately, and must be re-adjusted every day. The photoperiod
is the most dominant environmental Zeitgeber (time giver) for
the phase entrainment of circadian oscillators in all investigated
organisms (Damiola et al., 2000; Reppert and Weaver, 2002). The
SCN integrates luminous stimuli, through the retina and coor-
dinates accordingly the peripheral « slave »clocks through direct
hormonal and neuronal signals or via indirect cues such as body
temperature or feeding time. The current molecular model for
the generation of circadian oscillations is based on interlocked
negative feedback loops in gene expression. In mammals, the two
PAS-domain helix-loop-helix transcriptional activators BMAL1
(Brain and muscle ARNT-like protein 1) and CLOCK (Circadian
locomotor output cycles kaput) form a heterodimer that activates
Per (Period) and Cryptochrome (Cry) transcription (as illus-
trated in Figure 1; Ripperger and Albrecht, 2012). Once PER and
CRY proteins accumulate, they form nuclear complexes that inter-
fere with BMAL1/CLOCK mediated transactivation, and therefore
inhibit their own transcription. This negative feedback loop gen-
erates cycles of around 24 h in gene expression (Ripperger and
Schibler, 2006; Lowrey and Takahashi, 2011). In addition, post-
translational events such as the control of protein phosphory-
lation, sumoylation, acetylation, O-GlcNAcylation, degradation,
and nuclear entry, contribute critically to the generation of daily
oscillations in clock gene products (Cardone et al., 2005; Gal-
lego and Virshup, 2007; Asher et al., 2008; Nakahata et al., 2008;
Durgan et al., 2011; Reischl and Kramer, 2011; Kim et al., 2012).
Central and peripheral clocks have a similar molecular makeup.
Moreover, this rhythm generating circuitry is functional in most
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FIGURE 1 |The network of the mammalian molecular oscillator.The
core loop (red shaded circle), responsible for generating rhythms of about
24 h, is composed of activation of the Per genes by BMAL1 (red) and
CLOCK (blue) and the increasing repression of Per gene expression by the
accumulation of its own gene product. The feedback inhibition by the PER
proteins is delayed by posttranslational modifications and interaction with
the CRY proteins (not shown). In the stabilizing loop (blue circle), the
Rev-Erbα gene (Reverse-erb alpha) is also activated by BMAL1 and CLOCK
(not shown) and later on repressed by the PER proteins but immediately
REV-ERBα starts to inhibit transcription of the Bmal1 and Clock genes and
of its own gene. PER2 can interact with REV-ERBα (or PPARα, not shown)
to regulate the Bmal1 gene. The overall organization of the network allows
for a tight synchronization of the core and stabilizing loops. Adapted from
Ripperger and Albrecht (2012).
cell types, including primary and immortalized cell lines (Bal-
salobre et al., 1998; Nagoshi et al., 2004). The cellular clocks
are cell-autonomous, self-sustained, and resilient to temperature
changes and cell division (Dibner et al., 2010).
To the best of our knowledge, potential disruption of the cir-
cadian clockwork has scarcely been explored in preeclampsia. The
first part of this review will focus on the clockwork machinery
underlying placental function, a major player in the pathology
of preeclampsia. We will then explore the indirect evidence of
circadian misalignment in preeclampsia, such as disruption of
the physiological circadian pattern of blood pressure (BP) and
conclude with potential clinical implications, perspectives, and
unsolved research questions.
CLOCKWORK AND PLACENTAL FUNCTION
Little information is available regarding clock machinery function
in the placenta. Frigato et al. investigated clock gene expression
in human placenta. This study suggests a circadian expression
pattern for Per2, Dec1, and DBP transcripts in in vitro synchro-
nized HTR/SVneo cells established from a human extra villous
trophoblast during the first trimester of pregnancy. Interestingly,
the expression of these genes was preserved and exhibited even
higher oscillation amplitude under hypoxic conditions, proba-
bly due to the similarities between extra villous trophoblast and
tumor cells. In addition, the response of the circadian clock to
hypoxia could represent an adaptive mechanism providing ade-
quate vascularization to answer placental needs (Frigato et al.,
2009). Expression of vascular endothelial growth factor (VEGF)
has also been explored. VEGF oscillation started only 30 h follow-
ing the synchronization stimulus (serum shock), and its circadian
pattern remains questionable.
Two more studies reported the presence of canonical core clock
genes in the rodent placenta. Endogenous levels of core clock tran-
scripts Bmal1, Clock, Cry (Cry1-2), and Period (Per1-2) exhibited
oscillatory patterns in the murine gravid uterus, placenta, and
fetal membrane during the last third of gestation (Ratajczak et al.,
2010). In line with these findings, the level of circadian bio-
luminescence reporter Per2:luciferase oscillated in these tissues.
Interestingly the absolute expression levels of the core clock genes
were upregulated 2 days before the parturition, suggesting that
peripheral clocks in the reproductive tissues might be important
during gestation. An additional study showed the expression of
canonical core clock transcripts in two functionally distinct zones
of rat placenta, the labyrinth (involved in maternal-fetal exchange)
and the junctional zone (responsible for hormone production)
(Wharfe et al., 2011). While all the assayed clock transcripts were
expressed in both zones, their expression levels did not signifi-
cantly vary around-the-clock. In the labyrinth zone, Clock, Per1,
and Cry2 expression was higher compared to the junctional zone,
while the opposite tendency was observed for Bmal1, Per2, Per3,
and Cry1. A constant expression of VEGF over the circadian time
points was also demonstrated in the placenta in this study.
The physiological significance of these findings needs to be
further explored. Based on the two available in vivo studies in
rodent models, it is difficult to conclude whether the core clock
genes exhibit the oscillatory pattern in rodent placenta. However
the study performed in HTR/SVneo human primary cells syn-
chronized in vitro by serum shock (Frigato et al., 2009) strongly
suggests the existence of the functional placental circadian clock.
Moreover, this work and the study of rat placenta (Wharfe et al.,
2011) suggests that placental angiogenic factors like VEGF might
be candidates for the placental circadian clock regulation.
CIRCADIAN EXPRESSION OF PLACENTAL INFLAMMATORY MEDIATORS
Preeclampsia is characterized by a marked inflammatory state.
Whether this is the result of a placental ischemia and reperfusion
or an exaggerated maternal response to the allogenic fetus remains
uncertain (Sibai et al., 2005).
In their review, Waddell et al. mention recent results suggest-
ing that pro-inflammatory cytokines, particularly TNF-alpha, are
expressed in the placenta according to a circadian pattern. This has
also been observed for IL-6 and IL-1beta (Waddell et al., 2012). The
significance of rhythmic expression of placental pro-inflammatory
cytokines in physiological process such as parturition needs to be
determined.
CIRCADIAN PATTERN OF BLOOD PRESSURE: INDIRECT
EVIDENCE OF THE POTENTIAL ROLE OF THE CLOCK IN
PREECLAMPSIA
CIRCADIAN PATTERN OF BLOOD PRESSURE IN NORMAL PREGNANCIES
Arterial BP is one of the major physiological processes following
a circadian pattern. In non-pregnant women, BP is highest early
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in the morning. It increases again in the afternoon or late evening
and is at its lowest during the night, dipping to 10–20% less than
day time values.
Normotensive pregnancies preserve the normal BP circadian
pattern, but with a lower mean, as shown in the majority of the
control groups of the studies summarized in Table 1. BP tends to
decrease from the first trimester to the second trimester. It then
rises again to reach a non-pregnant value near term. The most
simple and clinical way to evaluate the nycthemeral pattern of the
BP is to monitor the 24 h ambulatory BP, and calculate the noctur-
nal dip. In clinical research, more sophisticated chronobiological
methods to evaluate oscillations of the BP are used. The circadian
pattern of arterial pressure in physiologic pregnancies compared
to the non-pregnant state display a less pronounced midline esti-
mating statistic of rhythm (mesor). Mesoris the arithmetical mean
of the measures of the biological variable, or the mean level of the
rhythm (Cugini et al., 1992; Benedetto et al., 1996). As mesoris the
measurable expression of the tonic level for a given periodic func-
tion, Cugini et al. suggest that the differences seen in the 24 h BP
pattern between the pregnant and the non-pregnant state lies in its
tonic regulation. This might be a mechanism that reduces the baric
impact of pregnancy and protects the arterial vascular system.
CIRCADIAN VARIATION OF BLOOD PRESSURE IN PREECLAMPSIA
Blood pressure diurnal variation in complicated pregnancies has
been studied since the 1950s in an attempt to understand the
underlying mechanisms of hypertensive disease, set norms for
gestational BP, and optimize screening tools for early detection.
Before the arrival of the chronobiological method of analysis,
BP variation was assessed by comparing means and gradients, or
by calculating the percentage of diurnal variation. Studies on the
subject are rather limited, with little or no detailed figures or char-
acteristics of the population included, making the validity of the
results questionable. However, these early studies reveal important
and interesting observations regarding possible BP rhythmicity
perturbations in complicated pregnancies. Table 1 summarizes
most of the published data.
When compared to normotensive pregnancies, pregnant
women with essential hypertension preserve a normal circadian
variation of BP but with a greater fall in BP at night (Seligman,
1971; Redman et al., 1976; Sawyer et al., 1981). These intriguing
results need to be confirmed in larger studies.
In preeclampsia, evolution of BP throughout pregnancy is dis-
tinct. Contrary to physiologically normal pregnancies, BP does
not decrease in the first trimester, but instead remains stable dur-
ing the first half of pregnancy and continuously increases until
delivery (Hermida et al., 2000). More interestingly, several studies
show consistent alterations in circadian rhythm. In preeclampsia,
the nocturnal decrease of BP is blunted and there is less variation
among BP circadian values (Seligman, 1971; Sawyer et al., 1981;
Beilin et al., 1983; Halligan et al., 1996). Later chronobiological
studies found concordant results, with a decrease in the oscillatory
amplitude of BP (i.e., the extent of oscillatory wave from MESOR)
in the two last trimesters of hypertensive and preeclamptic
pregnancies (Benedetto et al., 1996; Hermida et al., 2003).
In severe cases, patients may even display a reversed rhythm
with maximal BP values occurring at night (Redman et al., 1976;
Sawyer et al., 1981; Beilin et al., 1983). The reason for this blunted
or even reversed circadian pattern in preeclampsia is unknown.
Beilin et al. explored the correlation of pressor hormones with
the measured arterial pressure in three groups of 15 normoten-
sive, chronic hypertensive, and preeclamptic pregnancies. They
observed a suppression of plasma renin activity and angiotensin
II levels during the day and a loss of the diurnal pattern for
angiotensin II in preeclamptic women. A reversed pattern for the
norepinephrine sulfate level was found as well as a suggestion of
loss of the midnight drop in the free adrenaline plasma level. In the
preeclamptic group, four patients had nocturnal hypertension and
showed the lowest levels of plasma renin activity and angiotensin
II. Absence of an angiotensin II, adrenaline, or noradrenaline drop
at night in subjects with increased vascular reactivity could con-
tribute to their nocturnal hypertension, with a direct negative
feedback of the high BP on the renal vascular barostat (Beilin
et al., 1983).
Olofsson and Poulsen also found a reversed BP pattern in 12 of
the 56 women investigated for pregnancy-induced hypertension of
which, 36 had preeclampsia. As expected, reversed BP rhythm was
associated with the more severe form of preeclampsia (Olofsson
and Poulsen, 1997). Surprisingly, the study showed that women
with reversed rhythm delivered larger babies. The authors hypoth-
esized that a more stable BP, prolonged over the night, maintained
higher placental perfusion that was beneficial for the fetus.
Another pathophysiologic mechanism evoked by some authors
to explain the non-dipper pattern in the general hypertensive
population is linked to the pressure-natriuresis curve described
by Guyton et al. (1972). Some individuals, probably sub-groups,
such as menopausal women, that are salt-sensitive or with slight
renal alterations need to have an increased BP at nighttime in
order to excrete an excess of sodium retained during the day
(Pechere-Bertschi and Burnier, 2004). Preeclamptic women are
rather hypovolemic despite the edematous state, with an increased
sodium retention in the extravascular compartment as well as
a strong vasoconstrictive status. Non-dipper status observed in
preeclampsia could be a compensative mechanism to oppose the
increased sodium retention as well as an adaptive mechanism to
preserve fetal perfusion.
CLINICAL IMPLICATIONS
CIRCADIAN PATTERN OF BLOOD PRESSURE AS A PREDICTOR OF
PREECLAMPSIA
Identifying high-risk patients by early recording of a 24 h ambu-
latory BP monitoring (ABPM) and analyzing changes in the
circadian pattern of BP, could be an elegant, non-invasive, and eco-
nomic way of predicting hypertensive complications of pregnancy.
Screening for gestational hypertension (GH) is usually made
by office BP measurement. ABPM is commonly used as a con-
firmative diagnostic tool, when an isolated abnormal office BP is
measured. However, subtle differences in the BP pattern, although
well within the normal range, can be detected early in the course
of pregnancies that will later develop hypertensive complications
(Ayala and Hermida, 2013).
Circadian variability and pulse pressure
In a large prospective study, the Hermida et al. (2003) group
explored the circadian variability of BP as an early predictor of
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Table 1 | Summary of the main studies on BP and circadian pattern during normal and abnormal pregnancies.
Reference n Methods Results Comments
Seligman (1971) n=30 (10 normal BP, 10 HT, 10 PE) Automatic recorder (24 h)
Inpatients
Greater fall at night in HT
Reduced fall at night in PE
Characteristics of the subject
included are lacking (age, parity,
weeks gestation)
Results and figures not detailed
for every subject
Redman et al.
(1976)
n=19 [3 severe PE, 4 mild HT, 12
primigravida w/mild HT (6 on
methyldopa, 6 no treatment)]
Automatic recorder (48 h)
Inpatients, bedrest
At 24 and 36 w.g.
Reversed rhythm in severe PE
Normal pattern in mild HT
Characteristics of the women
included are lacking (age, parity)
Results and figures not detailed
for every subject
Sawyer et al.
(1981)
n=45 (15 normal BP, 15 chronic
HT, 15 mild PE), third trimester
DINAMAP (24 h)
Inpatients
Blunted fall at night in PE
No diurnal variation in two severe
PE (excluded from analysis)
Characteristics of the women
included are lacking (age, parity
not precised except for PE)
Beilin et al.
(1983)
n=31 [10 normal BP, 13 HT
(antenatal BP normal), 8 PE]
DINAMAP (24 h)
Inpatients
Same circadian rhythm in normo
and hypertensive groups
Two HT and three PE under
treatment when studied
>26 w.g. No fall in BP in all PE, with four
nocturnal HT
PE older, multiparous
Cugini et al.
(1992)
n=60 (30 non-pregnant, 30
pregnant women)
ABPM (24 h)
At 8–10, 18–20, and
32–34w.g.
Reduced means BP for
gestational HT. Values tend to
increase in the second and third
trimester
Benedetto et al.
(1996)
n=212 (73 controls, 48 GH, 38
PE, 53 mild to moderate HT)
DINAMAP (24 h)
Inpatients
BP oscillations less pronounced
in GH and PE
Circadian parameters obtained
by single cosinor method
Singleton pregnancy At 8–16, 20–25, 28–35,
36–40 w.g.
Severity of HT favor the loss of
diurnal rhythm, especially in PE
Halligan et al.
(1996)
n=48 (24 normal BP, 24 PE), 35
w.g.
ABPM (24 h) Blunted BP nocturnal fallin PE.
Inversely related to increase in
BP mean
Preliminary, cross-sectional
study
Comparison of means and
gradients
Tranquilli et al.
(1996)
n=114 (Normal BP, 36 IUGR,
birthweight<fifth percentile, 78
normal IUG and birthweight
ABPM (24 h)
At 24–28 w.g.
BP significantly elevated in IUGR
although still in normal range
Ayala et al.
(1997)
n=113 (71 uncomplicated
pregnancy, 28 GH, 14 PE)
ABPM (48 h)
Every 4 weeks after first
obstetric visit
Significant difference in BP
between healthy and
complicated pregnancies
present in the first 14 w.g.
Olofsson and
Poulsen (1997)
n=56 GH (of which 34 PE) ABPM (24 h)
Inpatients (range
23–40 weeks gestation)
12 SBP reversed rhythm, of
which 10 PE. Associated with a
more severe PE, smaller BP
variation, maintenance of fetal
growth, higher birthweight
No control group
Stoynev et al.
(1999)
n=31 pregnant women at low
risk for HT
Automatic recorder (48 h)
Inpatients
HR mesor increased in middle
and late pregnancy. BP mesor
unchanged
Hermida et al.
(2000)
n=202 (124 normal pregnancy, 55
GH, 23 PE)
ABPM (48 h)
Every 4 weeks after first
obstetric visit until delivery
Difference in circadian variability
present in the first 14 w.g.
Circadian parameters
established by population
multiple component-analysis
(Continued)
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Table 1 | Continued
Reference n Methods Results Comments
Brown et al.
(2001)
n=158 (63 PE, 68 GH, 27 HT) ABPM (24 h)
Inpatients or outpatients
High prevalence of nocturnal HT
in PE and GH/essential HT
Hermida et al.
(2003)
n=403 (235 uncomplicated
pregnancies, 128 GH, 40 PE)
ABPM (48 h)
Every 4 weeks after first
obstetric visit until delivery
Difference in the circadian
variability already in first
trimester
Circadian parameters
established by population
multiple component-analysis
Hermida et al.
(2004)
n=434 (245 uncomplicated
pregnancies 140 GH, 49 PE)
ABPM (48 h)
Every 4 weeks after first
obstetric visit until delivery
Significant difference in the 14
first w.g. between normal and
complicated pregnancies
Circadian parameters
established by population
multiple component-analysis
Comparison of the 24 h mean of
pulse pressure
BP, blood pressure; SBP, systolic blood pressure; DBP, diastolic blood pressure; ABPM, ambulatory blood pressure monitoring; HT, hypertension; GH, gestational
hypertension; IUGR, intrauterine growth retardation; w.g, weeks gestation; DINAMAP, device for indirect non-invasive automatic mean arterial pressure.
hypertensive complications of pregnancy. The authors showed a
highly statistically significant difference in the circadian variability
in BP between normotensive and complicated pregnancies, already
detectable in the 14 first weeks of gestation. Amplitude was also
significantly higher in the first and second trimesters of later com-
plicated pregnancies, with a tendency to decrease in the second
and third trimesters, as mentioned earlier, mainly due to a blunted
night drop in preeclamptic pregnancies.
Using the same study design, Hermida et al. compared the 24 h
mean of pulse pressure (PP) between healthy and complicated
pregnancies. PP is the measure of the pulsatile component of BP
which represents a marker of the cardiovascular risk in the general
population. A significant elevation in 24 h mean PP sampled by
ABPM was present in the first 14 weeks of gestation. It has to be
stressed that this subtle difference in later hypertensive pregnan-
cies appears while BP is still within the normal range (Hermida
et al., 2004).
Hyperbaric index
Hyperbaric index (HBI) refers to the area of BP excess above the
upper limit value. It has been evaluated as a diagnostic tool for
GH. Hermida et al. validated this approach prospectively in 1998
and found a test sensitivity of 93% for women screened in the first
trimester, and of 99% in the third trimester. Positive and nega-
tive predictive values averaged 96% in all trimester. The HBI was
abnormal 23 weeks before manifest hypertension (Hermida et al.,
1998). In preeclampsia, HBI is significantly higher after 20 weeks
gestation (Hermida and Ayala, 2002).
IMPLICATION OF CHRONOTHERAPY IN THE PREVENTION OF
PREECLAMPSIA USING LOW-DOSE ASPIRIN
Administration of low-dose aspirin has been shown to reduce
the overall risk of preeclampsia (Sibai et al., 1993). This protec-
tive property is more pronounced if aspirin is taken before or at
16 weeks of gestation with a 89% reduction of preterm preeclamp-
sia (Roberge et al., 2012b) and a ca. 90% decrease in relative risk
of severe preeclampsia (Roberge et al., 2012a).
Preeclampsia is associated with an imbalanced production of
prostacyclin (a vasodilator) and thromboxane A (a vasoconstrictor
and platelet aggregator),with a subsequent arteriolar vasoconstric-
tion and coagulation disorder. The protective effect of aspirin is
thought to be due to a selective decrease in thromboxane A pro-
duction with no influence on the prostacyclin level (Sibai et al.,
1993, 2003).
Amongst other properties, low-dose aspirin has been shown to
reduce BP. This action might be linked the antioxidative effect of
aspirin, with a reduction in vascular production of superoxide and
an increased release of nitric oxide (NO) (Hermida et al., 2005b).
Moreover, aspirin has been shown to influence secretion of pressor
hormones such as renin, aldosterone, cortisol, and catecholamine
(Snoep et al., 2009). Interestingly, this phenomenon seems to be
influenced by ingestion time. When taken at bedtime, aspirin is
effective in lowering BP whereas this effect is lost when taken in
the morning (Hermida et al., 2005a). Although not fully under-
stood, this might be related to the circadian secretion pattern of
BP regulators. As explored by Snoep et al. (2009) aspirin decreases
the nocturnal rise in activity of the renin-angiotensin-aldosterone
system and in cortisol and catecholamine levels when taken at
bedtime, but not in the morning. Another mechanism could
involve enhanced release of NO during the night, as exemplified
by Hermida et al. in a study comparing BP response to aspirin in
non-dipper hypertensive patients and dipper patients. Non-dipper
status is characterized by a reduced NO vascular production. When
administered at night, aspirin not only produced a significant
reduction in BP, but the reduction in the non-dipper group was
twice that observed in the dipper group (Hermida et al., 2005b).
This has been observed in normotensive, pre-hypertensive, and
mild hypertensive subjects, as well as in pregnant women at higher
risk for GH or preeclampsia (Hermida et al., 1997; Ayala et al.,
2013).
Ayala et al. conducted a randomized, placebo-controlled trial
on 350 women with an elevated risk of GH or preeclampsia, to
compare the effect of low-dose aspirin, when ingested at differ-
ent times of the day. The primary outcome was serious adverse
event, defined as preeclampsia, preterm delivery, intrauterine
growth retardation, and stillbirth. An additional endpoint was
the composite of these adverse events plus GH (Ayala et al.,
2013). In concordance with previous studies, women in the aspirin
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group had a significantly lower incidence of serious adverse out-
comes with or without GH. Reduction in risk of preeclampsia was
individually documented in the aspirin group (p= 0.41) with a
number needed to treat (NNT) of 16. This reduction in risk was
greater when aspirin was taken in the evening or at bedtime com-
pared to the placebo group plus the aspirin ingested at awakening
group (p< 0.01) and the NNT halved to 8.
In line with previous studies, there was no significant difference
in BP between placebo and aspirin ingested in the morning. There
was a significant decrease in BP when aspirin was taken 8 h after
awakening, and to a greater extent when it was taken at bedtime.
Administration of low-dose aspirin at bedtime represents an
easy and cost effective prophylaxia for women with a high risk of
developing preeclampsia.
MISALIGNMENT OF BIOLOGICAL RHYTHM AND RISK OF
PREECLAMPSIA
As introduced earlier, many physiological processes occur in phase
with environmental cues or Zeitgebers, the most important one
being the daily change in light intensity. Various occupations
require night work and iterative crossing of time zones. Health-
care professionals and security workers have to work night shifts,
whereas flight attendants and pilots are regularly confronted with
jetlag.
Disruption of the circadian rhythm has been associated with
impaired reproductive function and adverse pregnancy outcomes.
Women working night shifts or transmeridian travelers might be
at increased risk for spontaneous abortion, subfecundity, as well
as giving birth to premature babies or low birth weight babies
(Mahoney, 2010).
While physically demanding jobs have been associated with a
slight increase in GH and preeclampsia (Mozurkewich et al., 2000),
very few data are available on a potential link between shift work
and preeclampsia.
A Norwegian cross-sectional study conducted in 1989 showed
no association between shift work and prevalence of preeclampsia
(OR 1.3, CI 0.8–1.9) in the overall population studied (Wergeland
and Strand, 1997). However, authors found an interaction with
parity and prevalence of preeclampsia that was increased among
parous women working shifts (OR 2.0, 95% CI 1.1–3.6).
Haelterman et al. (2007) performed a case-control study in
women from six region of Quebec between 1997 and 1999. Evening
or night hours were not associated with an increased prevalence
of preeclampsia (1–6 weekly evening work hours: OR 1.0, 95% CI
0.6–1.7, 7–32 weekly evening work hours: OR 1.1, 95% CI 0.7–1.9,
≥1 weekly night work hours: OR 1.0 95% CI 0.5–2.0).
In their large cross-sectional study, Chang et al. (2010) did not
show any association between shift work and preeclampsia among
Taiwanese women between June 2005 and July 2006 (adjusted OR
0.96, 95% CI 0.59–1.57).
These three studies did not bring convincing evidence that shift
work increases the risk of preeclampsia.
DISCUSSION AND PERSPECTIVE
Recently, there has intense research addressing the relationship
between the circadian internal clock genes and some aspects of
cardiovascular and general health. Preeclampsia can be considered
as a stress test for cardiovascular diseases (Sattar and Greer, 2002),
and there is some evidence both in animal and human experi-
ments that circadian misalignment may be associated with this
pathology.
Early in pregnancy, some clock genes and cytokines are
expressed in the placenta according to a circadian pattern, with dif-
ferent oscillation amplitudes under pathologic conditions (Frigato
et al., 2009; Wharfe et al., 2011; Waddell et al., 2012).
In both normotensive and hypertensive populations, a non-
dipper status of the nocturnal BP has been linked to an increased
risk of target organ damage, microalbuminuria, adverse renal out-
come, and mortality. A non-dipping pattern of BP is associated
with an augmented risk of developing preeclampsia. Other vari-
ables of BP, like increased variability and PP, have been related to
abnormal pregnancies. It is unknown if the non-dipping status is a
compensative mean to excrete the higher rate of sodium retained
during the daytime in abnormal pregnancy. Indeed, absence or
blunted decrease of the BP during nighttime has been associated
with salt sensitivity of the BP, which is a well-known cardiovas-
cular risk factor. In animal models, mice lacking the core clock
components Cry1 and Cry2 (Cry-null mice), show salt-sensitive
hypertension due to abnormally high synthesis of aldosterone
(Okamura et al., 2011). As mentioned by Olofsson and Poulsen
(1997) an adaptive mechanism to preserve fetal perfusion should
also be considered.
Concordant data show that when started early in preg-
nancy, low-dose aspirin is effective in reducing the overall risk
of preeclampsia, but especially the risk of preterm and severe
preeclampsia (Roberge et al., 2012a,b). Based on chronothera-
peutic studies, bedtime rather than morning time ingestion has
been shown to reduce BP and seems to considerably improve the
prophylactic property of aspirin (Ayala et al., 2013). This sim-
ple, safe, and cost effective way to improve the outcome of some
high-risk pregnancies should encourage clinicians to prescribe this
medication in the evening.
High-risk pregnancies are currently identified according to per-
sonal risk factors. Development of an efficient screening tool
for early detection of high-risk pregnancies, especially among
healthy nulliparous, has yet to be achieved. Analysis of various
parameters recorded by ABPM allows detection of differences
in BP patterns very early in pregnancies that are later compli-
cated by preeclampsia. However, these differences remain subtle
and within the normally accepted physiological range. Setting
of ABP normal values for each trimester and a standardized
analysis of BP circadian pattern convenient to clinical use are
still required. Moreover, there are concerns about the repro-
ducibility of the circadian pattern by ABPM, as tolerance to the
device varies among patients and can disrupt sleep. The valid-
ity of ABPM still has to be confirmed before implementing it
in clinical practice for early detection of hypertensive diseases of
pregnancy.
Many professional fields demand an around-the-clock activ-
ity, exposing pregnant workers to artificial lights, irregular and
night shifts, as well as disturbed sleep habits. Shift work has
been identified as a risk factor for diseases such as cancer (Straif
et al., 2007). However, very few cross-sectional studies explored
disruption of circadian rhythm as an occupational risk factor
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for preeclampsia, with no persuasive evidence. Considering that
modern society increasingly upsets our biological rhythm, this
question has to be addressed for preeclampsia, a major public
health concern.
Altogether, this review highlights the need for further genetic,
experimental, and clinical studies to explore the rhythmic-
ity of placental function, develop powerful screening tools for
preeclampsia, and verify whether a disrupted circadian rhythm
represents an occupational risk factor for working pregnant
women.
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